Apr 2 |
Yield10 Bioscience, Inc. (YTEN) Q4 2023 Earnings Call Transcript
|
Apr 1 |
Yield10 Bioscience GAAP EPS of -$0.27 beats by $0.03
|
Apr 1 |
Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results
|
Apr 1 |
Earnings Scheduled For April 1, 2024
|
Mar 28 |
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024
|
Mar 26 |
Yield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canada
|
Mar 21 |
Crude Oil Moves Lower; Accenture Shares Tumble After Q2 Results
|
Mar 21 |
USDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the United States
|
Feb 29 |
Yield10 Bioscience Reports that Proprietary Varieties of Winter Camelina Show Tolerance to Commonly Used Herbicides in First Field Tests
|
Feb 14 |
Yield10 Bioscience Grants Global License to VISION Bioenergy Oilseeds for Herbicide Tolerant Camelina Cultivated for the Production of Biofuel Feedstock
|